Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 26 sec ago

Akers Biosciences Signs Agreement With Medline -- a Major US Distributor

Wed, 06/25/2014 - 15:10
THOROFARE, N.J., June 25, 2014 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AKR.L) (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announc...
Diagnostics, Distribution
Akers Biosciences, Medline, Heparin, Heparin-Induced Thrombocytopenia

Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer

Tue, 06/24/2014 - 19:07
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Editas Medicine, a transformative genome editing company, today announced the appointment of Katrine S. Bosley as chief executive officer. Ms. Bosley brings to Editas more than 20 years of experienc...
Biopharmaceuticals, Personnel
Editas Medicine, genome editing

Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices

Tue, 06/24/2014 - 19:01
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien (COV) today announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company. The lawsuit alleges ...
Devices, Litigation
Covidien, Johnson & Johnson, Ethicon Endo-Surgery, Harmonic ACE+7

NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck

Tue, 06/24/2014 - 12:41
Omron Healthcare Will Distribute in Japan WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--NeuroMetrix, Inc. (NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicia...
Devices, Regulatory
NeuroMetrix, NC-stat DPNCheck, diabetic peripheral neuropathy

Covidien Announces European Launch of Pipeline(TM) Flex Embolization Device

Tue, 06/24/2014 - 12:33
Minimally-invasive flow diversion device for unruptured brain aneurysms designed for more accurate, controlled placement1 DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Further strengthening its broad line of neurovascular products to treat u...
Devices, Neurosurgery, Interventional, Product Launch
Covidien, Pipeline Flex, embolization, aneurysm

Spacelabs Signs Global Distribution Agreement for Analgesia Pain Monitor

Tue, 06/24/2014 - 12:27
SNOQUALMIE, Wash.--(Healthcare Sales & Marketing Network)--Spacelabs Healthcare has completed a global partnership agreement with Mdoloris Medical Systems. Mdoloris produces the ANI monitor, which continuously monitors the pain level of patients. Use of th...
Devices, Monitoring, Distribution
Spacelabs Healthcare, Mdoloris Medical Systems, ANI monitor

Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.

Mon, 06/23/2014 - 19:19
WOODCLIFF LAKE, N.J., June 23, 2014 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Barry Lederman to the position of Vice President and Chief Fin...
Biopharmaceuticals, Personnel

Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs

Mon, 06/23/2014 - 19:16
Seasoned Industry Executive to Lead Medical Affairs MENLO PARK, Calif., June 23, 2014 -- (Healthcare Sales & Marketing Network) -- Versartis, Inc. (VSAR), an endocrine-focused biopharmaceutical company that is developing VRS-317, a novel, long-acting fo...
Biopharmaceuticals, Personnel

ARIAD Announces Three Key Appointments to Its Global Management Team

Mon, 06/23/2014 - 19:11
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--ARIAD Pharmaceuticals, Inc. (ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and ...
Biopharmaceuticals, Personnel
ARIAD Pharmaceuticals

Itamar Medical Ltd. signs strategic marketing and distribution agreement for its EndoPAT(TM) device with premier medical device maker Nihon Kohden Japan

Mon, 06/23/2014 - 19:06
The agreement follows in the wake of two recently concluded strategic agreements with Philips and Medtronic The EndoPAT™ device, employed in non-invasive assessment of arterial health, provides indications used to assess the risk of cardiovascular even...
Devices, Distribution
Itamar Medical, Nihon Kohden, EndoPAT, endothelial function

Bayer HealthCare and Dimension Therapeutics to Develop Novel Gene Therapy for Hemophilia A

Mon, 06/23/2014 - 11:48
LEVERKUSEN, Germany, June 23, 2014 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare (Bayer) and Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, have entered...
Bayer HealthCare, Dimension Therapeutics, gene therapy, hemophilia

Dimension Therapeutics Raises $30M Financing

Mon, 06/23/2014 - 11:44
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing. New investor OrbiMed joined existing ...
Biopharmaceuticals, Venture Capital
Dimension Therapeutics, gene therapy

New Philips NeuroSuite Reveals the Brain's Vascular Network like Never Before

Mon, 06/23/2014 - 11:39
NeuroSuite interventional X-ray system enhances minimally invasive neurological treatment Solution supports more effective device guidance and placement in live image-guided neuroradiology procedures, extending treatment options First installation ...
Devices, Neurology, Interventional, Radiology
Royal Philips Electronics, NeuroSuite, neuroradiology

23andMe Appoints Angela Wonson Vice President of Communications

Fri, 06/20/2014 - 18:02
Health Care Communications Industry Veteran Joins 23andMe Leadership Team MOUNTAIN VIEW, Calif.--(Healthcare Sales & Marketing Network)--23andMe, the leading personal genetics company, today announced the appointment of Angela Wonson as vice president, ...
Diagnostics, Personalized Medicine, Personal
23andMe, personal genetics, genetic testing

ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and Marketing

Fri, 06/20/2014 - 17:57
MIAMI LAKES, Fla., June 20, 2014 -- (Healthcare Sales & Marketing Network) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, has appointed William Creech as Vice President Sales and Marketing. Mr. Creech has over...
Diagnostics, Personnel
ERBA Diagnostics

IsoRay Announces New Russian and Peruvian International Distributor Agreements for the Sale of IsoRay's Full Line of Products

Fri, 06/20/2014 - 17:52
RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay, Inc. (NYSE MKT: ISR) (, announced today that it has entered into two (2) international distribution agreements: the first with MedikorPharma-Ural LLC for the Russian mark...
Devices, Oncology, Distribution
IsoRay, MedikorPharma-Ural, Surgicorp SRL, brachytherapy

Vascular Pathways Names Scott Pease as Vice President of Regulatory Affairs and Quality Assurance

Thu, 06/19/2014 - 13:06
NAPLES, FL--(Healthcare Sales & Marketing Network) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire-guided technology for peripheral intravascular access, today announced the company has appointed Scott Pease as ...
Devices, Personnel
Vascular Pathways, AccuCath

Integra LifeSciences Celebrates 25th Anniversary

Thu, 06/19/2014 - 12:55
PLAINSBORO, N.J., June 19, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART), a world leader in medical technology, today announced that June 2014 marks the 25th anniversary of its founding. Twenty-five y...
Devices, Orthopaedic, Neurosurgery
Integra LifeSciences

Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A

Thu, 06/19/2014 - 12:50
Supports Clinical Development of X-82, Next-Generation VEGFR/PDGFR Inhibitor Being Developed to Treat Solid Tumors and Ophthalmological Diseases WEST PALM BEACH, Fla.--(Healthcare Sales & Marketing Network)--Tyrogenex Inc., an Xcovery Group company focu...
Biopharmaceuticals, Ophthalmology, Venture Capital
Xcovery Group, Brace Pharma, X-82, macular degeneration

Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders

Thu, 06/19/2014 - 12:36
Company’s Drug Discovery Platform Based on Groundbreaking Science on mTORC1 Pathway by Scientific Founder David Sabatini of the Whitehead Institute CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Navitor Pharmaceuticals, Inc., a biopharmaceuti...
Biopharmaceuticals, Venture Capital
Navitor Pharmaceuticals, mTORC1

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong